Thromboembolic risk with <scp>JAK</scp> inhibitors in atopic dermatitis: Context, caution and clinical relevance
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Authors
- Joseph Caravaglio (ORCID: https://orcid.org/0009-0001-0972-9311)
Institutions
- University of Central Florida (US)
- Northeast Florida Healthy Start Coalition (US)
- Southeast Radiation Oncology Group (US)
Publication Details
- Journal
- Journal of the European Academy of Dermatology and Venereology
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1111/jdv.70235
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00